1. Home
  2. ARW vs KYMR Comparison

ARW vs KYMR Comparison

Compare ARW & KYMR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Arrow Electronics Inc.

ARW

Arrow Electronics Inc.

HOLD

Current Price

$112.20

Market Cap

5.8B

Sector

Technology

ML Signal

HOLD

Logo Kymera Therapeutics Inc.

KYMR

Kymera Therapeutics Inc.

HOLD

Current Price

$66.59

Market Cap

4.7B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
ARW
KYMR
Founded
1935
2015
Country
United States
United States
Employees
N/A
N/A
Industry
Electronic Components
Medicinal Chemicals and Botanical Products
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
5.8B
4.7B
IPO Year
N/A
2020

Fundamental Metrics

Financial Performance
Metric
ARW
KYMR
Price
$112.20
$66.59
Analyst Decision
Sell
Strong Buy
Analyst Count
2
19
Target Price
$102.00
$69.58
AVG Volume (30 Days)
491.5K
698.8K
Earning Date
10-30-2025
11-04-2025
Dividend Yield
N/A
N/A
EPS Growth
0.79
N/A
EPS
9.05
N/A
Revenue
$29,389,382,000.00
$43,735,000.00
Revenue This Year
$9.50
$20.81
Revenue Next Year
$4.23
N/A
P/E Ratio
$12.42
N/A
Revenue Growth
3.16
N/A
52 Week Low
$86.50
$19.45
52 Week High
$134.74
$68.80

Technical Indicators

Market Signals
Indicator
ARW
KYMR
Relative Strength Index (RSI) 55.98 60.17
Support Level $101.79 $63.69
Resistance Level $108.74 $68.78
Average True Range (ATR) 2.34 2.85
MACD 1.11 -0.20
Stochastic Oscillator 94.31 63.67

Price Performance

Historical Comparison
ARW
KYMR

About ARW Arrow Electronics Inc.

Arrow Electronics Inc. is a provider of products, services, and solutions to industrial and commercial users of electronic components and enterprise computing solutions. It has one of the world's broadest portfolios of product offerings available from electronic components and enterprise computing solutions suppliers, coupled with a range of services, solutions, and software, the company helps industrial and commercial customers introduce products, reduce their time to market, and enhance their overall competitiveness. The company has two business segments, the components business and the enterprise computing solutions.

About KYMR Kymera Therapeutics Inc.

Kymera Therapeutics Inc is a clinical-stage biopharmaceutical company dedicated to reinventing the treatment of human disease through the development of, differentiated medicines that address health problems and that meaningfully improve patients' lives. It is committed to novel technologies to address targets that have known disease-causing biology, but which have not been drugged, or have been inadequately drugged, often based on limitations of existing technologies. Its approach is intended to discover and develop a new generation of medicines in a disease-agnostic manner. Its product pipelines are STAT6, TYK2, and IRAK4.

Share on Social Networks: